• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

EGA Becomes Medicines for Europe

Article

March 10, 2016.

The European Generic and Biosimilar Medicines Association (EGA) has changed its name to Medicines for Europe.   In a press release issued today, Medicines for Europe President Jacek Glinka explained that the repositioning "reflects our industries’ purpose and strategic objectives ... [W]e have been through an incredible journey responding to the changes that have taken place in the pharmaceutical industry and European healthcare environment. I invite stakeholders and policy-makers to engage with us to deliver access to high quality medicines for all European patients.”   http://www.medicinesforeurope.com/

Recent Videos